These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 26477383)

  • 1. Development of HepG2-derived cells expressing cytochrome P450s for assessing metabolism-associated drug-induced liver toxicity.
    Xuan J; Chen S; Ning B; Tolleson WH; Guo L
    Chem Biol Interact; 2016 Aug; 255():63-73. PubMed ID: 26477383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cytochrome P450s (CYP)-overexpressing HepG2 cells for assessing drug and chemical-induced liver toxicity.
    Chen S; Wu Q; Li X; Li D; Mei N; Ning B; Puig M; Ren Z; Tolleson WH; Guo L
    J Environ Sci Health C Toxicol Carcinog; 2021; 39(1):68-86. PubMed ID: 33576714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of hepatic cytochrome P450s in the cytotoxicity of dronedarone.
    Chen S; Wu Q; Ning B; Bryant M; Guo L
    Arch Toxicol; 2018 Jun; 92(6):1969-1981. PubMed ID: 29616291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of hepatic cytochrome P450s in the cytotoxicity of sertraline.
    Chen S; Wu Q; Li X; Li D; Fan M; Ren Z; Bryant M; Mei N; Ning B; Guo L
    Arch Toxicol; 2020 Jul; 94(7):2401-2411. PubMed ID: 32372212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of hepatic cytochrome P450s in the cytotoxicity of lapatinib.
    Chen S; Li X; Li Y; He X; Bryant M; Qin X; Li F; Seo JE; Guo X; Mei N; Guo L
    Toxicol Sci; 2023 Dec; 197(1):69-78. PubMed ID: 37788138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
    Westerink WM; Schoonen WG
    Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the roles of cytochrome P450 (CYPs) in the metabolism and cytotoxicity of perhexiline.
    Ren Z; Chen S; Qin X; Li F; Guo L
    Arch Toxicol; 2022 Dec; 96(12):3219-3231. PubMed ID: 36083301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites.
    Marill J; Cresteil T; Lanotte M; Chabot GG
    Mol Pharmacol; 2000 Dec; 58(6):1341-8. PubMed ID: 11093772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18.
    Minoletti C; Dijols S; Dansette PM; Mansuy D
    Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
    Zanger UM; Schwab M
    Pharmacol Ther; 2013 Apr; 138(1):103-41. PubMed ID: 23333322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of CYP 3A4 and 1A1 in amiodarone-induced hepatocellular toxicity.
    Wu Q; Ning B; Xuan J; Ren Z; Guo L; Bryant MS
    Toxicol Lett; 2016 Jun; 253():55-62. PubMed ID: 27113703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids.
    Marill J; Capron CC; Idres N; Chabot GG
    Biochem Pharmacol; 2002 Mar; 63(5):933-43. PubMed ID: 11911845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans.
    Gustafsson F; Foster AJ; Sarda S; Bridgland-Taylor MH; Kenna JG
    Toxicol Sci; 2014 Jan; 137(1):189-211. PubMed ID: 24085192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative cytochrome P450 -1A1, -2A6, -2B6, -2C, -2D6, -2E1, -3A5 and -4B1 expressions in human larynx tissue analysed at mRNA level.
    Sarikaya D; Bilgen C; Kamataki T; Topcu Z
    Biopharm Drug Dispos; 2006 Nov; 27(8):353-9. PubMed ID: 16894644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang.
    Lee SY; Lee JY; Kang W; Kwon KI; Park SK; Oh SJ; Ma JY; Kim SK
    Food Chem Toxicol; 2013 Jan; 51():343-9. PubMed ID: 23104244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetaminophen-Induced Liver Injury Alters Expression and Activities of Cytochrome P450 Enzymes in an Age-Dependent Manner in Mouse Liver.
    Bao Y; Wang P; Shao X; Zhu J; Xiao J; Shi J; Zhang L; Zhu HJ; Ma X; Manautou JE; Zhong XB
    Drug Metab Dispos; 2020 May; 48(5):326-336. PubMed ID: 32094214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
    Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
    Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
    Utkarsh D; Loretz C; Li AP
    Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver.
    Furukawa M; Nishimura M; Ogino D; Chiba R; Ikai I; Ueda N; Naito S; Kuribayashi S; Moustafa MA; Uchida T; Sawada H; Kamataki T; Funae Y; Fukumoto M
    Cancer Sci; 2004 Jun; 95(6):520-9. PubMed ID: 15182434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro micronucleus test in HepG2 transformants expressing a series of human cytochrome P450 isoforms with chemicals requiring metabolic activation.
    Hashizume T; Yoshitomi S; Asahi S; Matsumura S; Chatani F; Oda H
    Mutat Res; 2009; 677(1-2):1-7. PubMed ID: 19501186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.